FDA approves first new antibiotic for UTIs in nearly 30 years
The FDA approved a new antibiotic for UTIs from drugmaker GSK. The drug, Blujepa, is for women and girls ages 12 and up.
Medscape3d
Urine Dipstick Shows Higher Accuracy Than Laboratory Analysis for UTI Detection in Febrile Infants
Urine dipstick demonstrates higher sensitivity and specificity than laboratory urinalysis for diagnosing urinary tract ...
theAsianparent on MSN13d
What is Dysuria in Children? Here are the Causes and How to Treat It
Khawatir melihat si kecil yang mengalami anyang-anyangan? Inilah beberapa cara yang bisa dilakukan untuk mengatasinya.
Mint3d
UTI Children's Hybrid Fund- Direct
The UTI Children's Hybrid Fund- Direct has an AUM of 4316.01 crores & has delivered CAGR of 13.82% in the last 5 years. The fund has an exit load of 0.00% and an expense ratio of 1.54%.
FDA approves new UTI antibiotic that may help patients with recurring infections
Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...
Verywell Health on MSN7d
Can a UTI Go Away Without Treatment?
An uncomplicated urinary tracti infection (UTI) could go away on its own, but waiting increases the risk of symptoms turning ...
GSK's Blujepa Approved For Treatment of UTIs in Women, Children
GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...
Mint4d
UTI Children's Hybrid Fund - Direct - Scholarship Plan
The UTI Children's Hybrid Fund - Direct - Scholarship Plan has an AUM of 4316.01 crores & has delivered CAGR of 13.82% in the last 5 years. The fund has an exit load of 0.00% and an expense ratio ...